China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People's Republic of China and internationally. It also provides related health services. The company offers OTC products, including cold, skin, gastrointestinal, cough relieving, orthopedics, and pediatrics drugs; prescription drug products in traditional Chinese medicine, tumors, cardiovascular and cerebrovascular, digestive system, orthopedics, and pediatrics; Chinese medicine injections; formula granules; and anti-infective drugs. It sells its products under 999 family medicine brands, Sanjiuweitai series, 999 Ganmaoling series, 999 dermatitis series, and other products. The company was formerly known as Sanjiu Pharmaceutical Co., Ltd. and changed its name to China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. in February 2010. The company was founded in 1999 and is based in Shenzhen, the People's Republic of China. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a subsidiary of China Resources (Holdings) Co., Ltd.
China Resourcesnjiu Medical & Pharmaceutical Dividend Announcement
• China Resourcesnjiu Medical & Pharmaceutical announced a semi annually dividend of ¥1.00 per ordinary share which will be made payable on 2024-11-29. Ex dividend date: 2024-11-29
• China Resourcesnjiu Medical & Pharmaceutical annual dividend for 2024 was ¥2.50
• China Resourcesnjiu Medical & Pharmaceutical annual dividend for 2023 was ¥0.77
• China Resourcesnjiu Medical & Pharmaceutical's trailing twelve-month (TTM) dividend yield is 5.62%
• China Resourcesnjiu Medical & Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 74.13%
• China Resourcesnjiu Medical & Pharmaceutical's dividend growth over the last five years (2018-2023) was 16.80% year
• China Resourcesnjiu Medical & Pharmaceutical's dividend growth over the last ten years (2013-2023) was 14.42% year
China Resourcesnjiu Medical & Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-29 | ¥1.00 | semi annually | 2024-11-29 |
2024-06-14 | ¥1.50 | semi annually | 2024-06-14 |
2023-06-15 | ¥0.77 | semi annually | 2023-06-15 |
2022-08-12 | ¥0.66 | semi annually | 2022-08-12 |
2021-07-09 | ¥0.38 | semi annually | 2021-07-09 |
2020-07-16 | ¥0.33 | semi annually | 2020-07-16 |
2019-08-08 | ¥0.30 | semi annually | 2019-08-08 |
2018-06-21 | ¥0.35 | semi annually | 2018-06-21 |
2017-07-14 | ¥0.12 | semi annually | 2017-07-14 |
2016-07-15 | ¥0.12 | semi annually | |
2015-07-10 | ¥0.31 | semi annually | |
2014-07-11 | ¥0.20 | semi annually | |
2013-07-26 | ¥0.20 | semi annually |
China Resourcesnjiu Medical & Pharmaceutical Dividend per year
China Resourcesnjiu Medical & Pharmaceutical Dividend growth
China Resourcesnjiu Medical & Pharmaceutical Dividend Yield
China Resourcesnjiu Medical & Pharmaceutical current trailing twelve-month (TTM) dividend yield is 5.62%. Interested in purchasing China Resourcesnjiu Medical & Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
China Resourcesnjiu Medical & Pharmaceutical Financial Ratios
China Resourcesnjiu Medical & Pharmaceutical Dividend FAQ
Other factors to consider when evaluating China Resourcesnjiu Medical & Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy China Resourcesnjiu Medical & Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: China Resourcesnjiu Medical & Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, China Resourcesnjiu Medical & Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, China Resourcesnjiu Medical & Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from China Resourcesnjiu Medical & Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: China Resourcesnjiu Medical & Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, China Resourcesnjiu Medical & Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: China Resourcesnjiu Medical & Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of China Resourcesnjiu Medical & Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review China Resourcesnjiu Medical & Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.